NexImmune, Inc. (NEXI)
OTCMKTS: NEXI · Delayed Price · USD
1.770
-0.140 (-7.33%)
Jul 22, 2024, 10:10 AM EDT - Market open
NexImmune Employees
NexImmune had 6 employees as of December 31, 2023. The number of employees decreased by 44 or -88.00% compared to the previous year.
Employees
6
Change (1Y)
-44
Growth (1Y)
-88.00%
Revenue / Employee
$353,426
Profits / Employee
-$4,309,432
Market Cap
2.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -44 | -88.00% |
| Dec 31, 2022 | 50 | -24 | -32.43% |
| Dec 31, 2021 | 74 | 30 | 68.18% |
| Dec 31, 2020 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
NEXI News
- 5 months ago - NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 months ago - NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 8 months ago - Here's why penny stocks like GGE, NEXI, ALT, HCDI are pumping - Invezz
- 9 months ago - NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes - GlobeNewsWire
- 9 months ago - NexImmune Announces Presentations at The Society for Immunotherapy of Cancer's 38th Annual Meeting - GlobeNewsWire
- 9 months ago - NexImmune Announces 1-for-25 Reverse Stock Split - GlobeNewsWire
- 11 months ago - NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development Strategy - GlobeNewsWire
- 1 year ago - NexImmune Reports Second Quarter 2023 Financial Results and Provides Business Updates - GlobeNewsWire